Alcohol Use Disorder

NIH Research Shows Increasing Prevalence & Severity of Cannabis Use Disorder in US Adults, While Alcohol Use Disorder Steadies or Declines a Bit

New findings from the NIH’s National Institute on Drug Abuse (NIDA) show that the prevalence of cannabis use disorder (CUD) among American adults, both male and female and across multiple age groups… Read More

Two Medicines for Alcohol Use Disorder May Be Effective in Different, Non-Overlapping Patient Subgroups, Animal Tests Suggest

Researchers led by a BBRF grantee report results of experiments that have potentially valuable precision-medicine implications for treating people with alcohol-use disorder (AUD). Read More

GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity

Researchers have reported positive results in the first clinical trial testing the diabetes and weight-loss medicine semaglutide (Ozempic, Wegovy) in treatment-seeking patents with alcohol use… Read More

GLP-1 Drug Semaglutide (Ozempic, Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder

A preliminary, phase 2 clinical trial has shown the potential benefit of a class of popular medications so far approved for control of diabetes and obesity to help reduce alcohol consumption and… Read More

Alcohol-Regulating Hormone Delivered in Combination With GLP-1 Drug Could Have Potential Application in Alcohol Use Disorder, Animal Study Suggests

Researchers led by a BBRF grantee report new research extending knowledge about how a naturally occurring hormone called FGF21 helps to regulate alcohol consumption. Using a synthetic analogue of the… Read More

Alcohol Use Disorder

TOPICS

Tags

ABOUT US

CONTACT US